Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-alpha in mice with acute graft-versus-host disease

被引:35
作者
Falzarano, G
Krenger, W
Snyder, KM
Delmonte, J
Karandikar, M
Ferrara, JLM
机构
[1] DANA FARBER CANC INST, DIV PEDIAT ONCOL, BOSTON, MA 02115 USA
[2] CHILDRENS HOSP, BOSTON, MA USA
[3] HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA
关键词
D O I
10.1182/blood.V87.7.2853.bloodjournal8772853
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graft-versus-host disease (GVHD) is associated with impaired B-cell responses. We investigated the mechanism of impaired proliferation of B cells in response to the mitogen lipopolysaccharide (LPS) by analyzing the production of tumor necrosis factor-alpha (TNF-alpha) and nitric oxide (NO), both of which have independently been described as important effector mechanisms in the pathogenesis of acute GVHD. A threefold decrease of mature surface Ig-positive (sIg(+)) B cells was observed in GVHD spleens isolated 2 weeks after transplant. However, proliferation of these cells in response to LPS was suppressed by more than 35-fold. Activated GVHD splenocytes secreted large amounts of TNF-alpha and NO in culture, Neutralization of TNF-alpha with anti-TNF-alpha antibody (Ab) both abrogated NO production and restored LPS-induced proliferation of B cells to levels found in non-GVHD control mice. The specific inhibition of NO synthesis with L(G)-monomethyl-arginine (NNMA) restored splenocyte responses but did not significantly reduce TNF-alpha levels, showing that TNF-alpha per se did not cause immunosuppression. These data show that, during GVHD, induction of the MO pathway is an important mechanism that mediates B-cell hyporesponsiveness to LPS and that this pathway is induced by TNF-alpha. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:2853 / 2860
页数:8
相关论文
共 62 条
[21]  
HIBBS JB, 1987, J IMMUNOL, V138, P550
[22]  
Hoffman R A, 1994, Transpl Immunol, V2, P313, DOI 10.1016/0966-3274(94)90008-6
[23]  
HOFFMAN RA, 1990, J IMMUNOL, V145, P2220
[24]  
HOFFMAN RA, 1993, J IMMUNOL, V151, P1508
[25]  
HOFFMAN RA, 1995, CHIMERISM TOLERANCE, P79
[26]  
HOLDA JH, 1986, J IMMUNOL, V137, P3538
[27]   EVIDENCE THAT IFN-GAMMA IS RESPONSIBLE FOR NATURAL SUPPRESSOR ACTIVITY IN GVHD SPLEEN AND NORMAL BONE-MARROW [J].
HOLDA, JH ;
MAIER, T ;
CLAMAN, HN .
TRANSPLANTATION, 1988, 45 (04) :772-777
[28]  
HOLLER E, 1993, TRANSPL P, V25, P1234
[29]  
HOLLER E, 1990, BLOOD, V75, P1011
[30]  
HUCHET R, 1993, J IMMUNOL, V150, P2517